BRIEF published on 07/06/2026 at 20:05, 4 months 2 days ago Mise à jour mensuelle d'ABIONYX sur les droits de vote Euronext Paris Capital Social Droit De Vote Mise À Jour Financière ABIONYX Pharma
BRIEF published on 07/06/2026 at 20:05, 4 months 2 days ago ABIONYX: Details on Share Capital and Voting Rights Euronext Paris Share Capital Voting Rights AMF ABIONYX
PRESS RELEASE published on 07/06/2026 at 20:00, 4 months 2 days ago Inside Information / Other news releases ABIONYX Pharma discloses monthly statement of total voting rights and shares. Company focuses on innovative medicines development with lipid science expertise Shares Total Voting Rights ABIONYX Pharma Innovative Medicines Lipid Science
PRESS RELEASE published on 07/06/2026 at 20:00, 4 months 2 days ago Informations privilégiées / Autres communiqués ABIONYX Pharma communique les informations sur son capital social et ses droits de vote, avec 42 568 071 actions en circulation le 30 juin 2026 Droits De Vote Développement Capital Social Biopharma ABIONYX Pharma
BRIEF published on 07/06/2026 at 19:19, 4 months 2 days ago ABIONYX's Half-Yearly Review of the Liquidity Contract Liquidity Transactions TP ICAP Actions ABIONYX Pharma
BRIEF published on 07/06/2026 at 19:19, 4 months 2 days ago Bilan semestriel du contrat de liquidité d'ABIONYX Transactions TP ICAP Actions Liquidité ABIONYX Pharma
PRESS RELEASE published on 07/06/2026 at 19:14, 4 months 2 days ago Informations privilégiées / Autres communiqués Bilan semestriel du contrat de liquidité portant sur les actions de la société ABIONYX Pharma, confié à la Société TP ICAP (Europe) SA, avec détails des transactions et soldes en espèces Contrat Bilan Semestriel Transactions Liquidité ABIONYX Pharma
BRIEF published on 06/30/2026 at 19:13, 4 months 8 days ago ABIONYX Pharma Secures Funding to Advance Sepsis Treatment ABIONYX Pharma CER-001 Financial Funding Sepsis Treatment ApoA-I Platform
BRIEF published on 06/30/2026 at 19:13, 4 months 8 days ago ABIONYX Pharma obtient des fonds pour faire progresser le traitement de la septicémie ABIONYX Pharma CER-001 Traitement De La Septicémie Plateforme ApoA-I Financement Financier
BRIEF published on 06/30/2026 at 19:13, 4 months 8 days ago ABIONYX Pharma en pleine expansion après son Assemblée Générale ABIONYX Pharma Sepsis CER-001 Assemblée Générale 2026 Plateforme ApoA-I
Published on 11/06/2026 at 22:15, 2 days 10 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 19 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 19 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 19 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/09/2026 at 08:15, 8 minutes ago EQS-Adhoc: Airbus SE: Airbus commences multi-year share buyback programme, with launch of the first tranche
Published on 11/09/2026 at 08:05, 17 minutes ago Onodrim Industries secures $300 million Series A at $1.3 billion valuation to strengthen Europe's defence and industrial foundations
Published on 11/09/2026 at 08:00, 23 minutes ago Custodian Property Income REIT plc: Further momentum with majority share-based acquisition strategy, purchasing an £11.0m property portfolio from eight syndicated investment vehicles
Published on 11/09/2026 at 07:00, 1 hour 23 minutes ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 1 hour 23 minutes ago BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 1 hour 23 minutes ago Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
Published on 11/09/2026 at 07:00, 1 hour 23 minutes ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour les dernières versions des tests BIOFIRE® FILMARRAY® Gastrointestinal Panels afin d’optimiser la détection des pathogènes gastrointestinaux, dont le norovirus
Published on 11/06/2026 at 19:06, 2 days 13 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
